In order to gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. CEOs, VPs of R&D, heads of product development, directors of regulatory affairs, and commercial leaders from manufacturers of flow imaging microscopes, analytical instruments firms, and technology suppliers were examples of supply-side sources. QC/QA directors, manufacturing science leads, analytical development heads, research scientists, and procurement managers from biopharmaceutical companies, contract manufacturing organizations (CMOs), contract development and manufacturing organizations (CDMOs), academic research institutions, biotechnology companies, and pharmaceutical quality control laboratories were examples of demand-side sources. Primary research obtained information on technology adoption trends, pricing tactics, service contract dynamics, and competitive positioning. It also validated product development pipelines and market segmentation.
Primary Respondent Breakdown:
By Designation: C-level Primaries (32%), Director Level (31%), Others (37%)
By Region: North America (32%), Europe (30%), Asia-Pacific (33%), Rest of World (5%)
Revenue mapping and instrument installation base analysis were used to determine the global market valuation. The methodology comprised:
Finding more than forty important manufacturers in Latin America, Europe, Asia-Pacific, and North America
Product mapping across several particle characterization technologies, such as imaging flow cytometry, static imaging systems, and dynamic imaging analyzers
Examination of annual revenues for flow imaging microscopy portfolios, both reported and modeled
coverage of producers accounting for 65–70% of the world market in 2024
Extrapolation to obtain segment-specific valuations utilizing top-down (manufacturer revenue validation) and bottom-up (instrument unit sales × ASP by region/application) methods
